Bioethical considerations in developing a biorepository for the Pneumonia Etiology Research for Child Health project.

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 855 N Wolfe St, Ste 600, Baltimore, MD 21218, USA.
Clinical Infectious Diseases (Impact Factor: 8.89). 04/2012; 54 Suppl 2:S172-9. DOI: 10.1093/cid/cir1063
Source: PubMed


The Pneumonia Etiology Research for Child Health (PERCH) project has the potential to provide a highly valuable resource of biospecimens that may be used to inform future studies on the causes of pneumonia. Designing a biorepository for this complex project was done in collaboration with a wide range of experts including bioethicists. In this paper, we describe the most significant ethical issues encountered related to the biorepository, focusing on its structure and informed consent. We also outline the proposed approach to the PERCH biorepository, which was designed to be sensitive to the ethical, practical, and cultural challenges inherent to the study. Through this process, we concluded that biorepository governance plans and strategies for managing informed consent should be implemented in a way to allow for careful study in order to better understand the attitudes of and impact on the stakeholders involved in the study.

Download full-text


Available from: Alan Regenberg, Oct 04, 2015
32 Reads
  • Pediatric infectious disease 03/1986; 5(2):247-52. DOI:10.1097/00006454-198603000-00017
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biobank research has been the focus of great interest of scholars and regulatory bodies who have addressed different ethical issues. On the basis of a review of the literature it may be concluded that, regarding some major themes in this discussion, a consensus seems to emerge on the international scene after the regular exchange of arguments in scientific journals. Broad or general consent is emerging as the generally preferred solution for biobank studies and straightforward instructions for coding will optimise privacy while facilitating research that may result in new methods for the prevention of disease and for medical treatment. The difficult question regarding the return of information to research subjects is the focus of the current research, but a helpful analysis of some of the issues at stake and concrete recommendations have recently been suggested.
    British Journal of Cancer 12/2008; 100(1):8-12. DOI:10.1038/sj.bjc.6604795 · 4.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The mapping and sequencing of the human genome promises rapid growth in understanding the genetically influenced mechanisms that underlie human disease. To realize this promise fully, it is necessary to relate genetic information to clinical phenotypes. Genetic tissue banking in clinical studies provides opportunities to analyze the genetic contribution to variation in response to treatments. The challenges to progress are likely to come from the complex organizational, social, political, and ethical issues that must be resolved in order to put clinical and DNA bank information together. Concerns about subjects' rights, informed consent, privacy, and ownership of genetic material require attention in the development of DNA banks. In this paper we describe one approach to the solution of these problems that was adopted by one clinical trials group, the Department of Veterans Affairs Cooperative Studies Program.
    Controlled Clinical Trials 07/2002; 23(3):222-39. DOI:10.1016/S0197-2456(02)00193-9
Show more